AgPlenus Announces Significant Progress in Its Fungicide Discovery Programs Targeting New Modes of Action, with Activity Against Resistant Septoria and Additional Fungal Pathogens
Evogene's subsidiary AgPlenus reported progress in two fungicide discovery programs targeting novel modes of action against Septoria tritici blotch, a major wheat disease. Active molecules generated by its ChemPass AI for Ag platform showed fungicidal activity including against resistant Septoria strains, reduced disease by 75% in plant tissue assays, and were independently corroborated by an external research organization.
Key figures
- Septoria market opportunity
- €1.2 billion
- Disease reduction in plant tissue assays
- 75%
- Historic european wheat fungicide share stb
- 70%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.